Application of TALEs, CRISPR/Cas and sRNAs as trans-acting regulators in prokaryotes

Current Opinion in Biotechnology

Volumn 29, Issue 1, 2014, Pages 46-54

  Copeland, Matthew F ^a   Politz, Mark C ^a   Pfleger, Brian F ^a  

^a University of Wisconsin Madison   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGY; GENE EXPRESSION; MICROORGANISMS; TOOLS;

CIS ACTINGS; POST-TRANSCRIPTIONAL; SPECIFIC SEQUENCES; TRANS ACTINGS;

NUCLEIC ACIDS;

DNA; TRANSCRIPTION ACTIVATOR LIKE EFFECTOR; TRANSCRIPTION FACTOR; TRANSFER RNA; UNCLASSIFIED DRUG; RNA; SMALL RNA; TRANS ACTING FACTOR;

BIOTECHNOLOGY; CRISPR CAS SYSTEM; DNA BINDING; DNA SEQUENCE; ESCHERICHIA COLI; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; GENE REPRESSION; GENE SILENCING; GENETIC ASSOCIATION; NONHUMAN; PRIORITY JOURNAL; PROKARYOTE; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; RNA EDITING; TRANSCRIPTION INITIATION; TRANSLATION INITIATION; ANIMAL; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; PROKARYOTIC CELL; GENE TARGETING; GENETIC TRANSCRIPTION; HOST PATHOGEN INTERACTION; PROTEIN DOMAIN; RNA BINDING; TRANSCRIPTION REGULATION;

ANIMALS; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS; DNA; GENE EXPRESSION REGULATION; HUMANS; PROKARYOTIC CELLS; RNA; TRANSCRIPTIONAL ACTIVATION;

EID: 84895962809     PISSN: 09581669     EISSN: 18790429     Source Type: Journal    
DOI: 10.1016/j.copbio.2014.02.010     Document Type: Review

References (71)

1. Khalil A.S., Collins J.J. Synthetic biology: applications come of age. Nat Rev Genet 2010, 11:367-379.
2. Lanza A.M., Crook N.C., Alper H.S. Innovation at the intersection of synthetic and systems biology. Curr Opin Biotechnol 2012, 23:712-717.
3. Doyle E.L., Stoddard B.L., Voytas D.F., Bogdanove A.J. TAL effectors: highly adaptable phytobacterial virulence factors and readily engineered DNA-targeting proteins. Trends Cell Biol 2013.
4. Mali P., Esvelt K.M., Church G.M. Cas9 as a versatile tool for engineering biology. Nat Methods 2013, 10:957-963.
5. Rusk N. Engineers meet small RNA. Nat Methods 2007, 4:986-987.
6. Li T., Huang S., Jiang W.Z., Wright D., Spalding M.H., Weeks D.P., Yang B. TAL nucleases (TALNs): hybrid proteins composed of TAL effectors and FokI DNA-cleavage domain. Nucleic Acids Res 2011, 39:359-372.
7. Wood A.J., Lo T.-W., Zeitler B., Pickle C.S., Ralston E.J., Lee A.H., Amora R., Miller J.C., Leung E., Meng X., et al. Targeted genome editing across species using ZFNs and TALENs. Science 2011, 333:307.
8. Mahfouz M.M., Li L., Shamimuzzaman M., Wibowo A., Fang X., Zhu J.-K. De novo-engineered transcription activator-like effector (TALE) hybrid nuclease with novel DNA binding specificity creates double-strand breaks. Proc Natl Acad Sci U S A 2011, 108:2623-2628.
9. Morbitzer R., Römer P., Boch J., Lahaye T. Regulation of selected genome loci using de novo-engineered transcription activator-like effector (TALE)-type transcription factors. Proc Natl Acad Sci U S A 2010, 107:21617-21622.
10. Huang P., Xiao A., Zhou M.G., Zhu Z.Y., Lin S., Zhang B. Heritable gene targeting in zebrafish using customized TALENs. Nat Biotechnol 2011, 29:699-700.
11. Sander J.D., Cade L., Khayter C., Reyon D., Peterson R.T., Joung J.K., Yeh J.R.J. Targeted gene disruption in somatic zebrafish cells using engineered TALENs. Nat Biotechnol 2011, 29:697-698.
12. Hruscha A., Krawitz P., Rechenberg A., Heinrich V., Hecht J., Haass C., Schmid B. Efficient CRISPR/Cas9 genome editing with low off-target effects in zebrafish. Development 2013, 140:4982-4987.
13. Malina A., Mills J.R., Cencic R., Yan Y., Fraser J., Schippers L.M., Paquet M., Dostie J., Pelletier J. Repurposing CRISPR/Cas9 for in situ functional assays. Genes Dev 2013, 27:2602-2614.
14. Cong L., Ran F.A., Cox D., Lin S., Barretto R., Habib N., Hsu P.D., Wu X., Jiang W., Marraffini L.A., et al. Multiplex genome engineering using CRISPR/Cas systems. Science 2013, 339:819-823.
15. Hockemeyer D., Wang H., Kiani S., Lai C.S., Gao Q., Cassady J.P., Cost G.J., Zhang L., Santiago Y., Miller J.C., et al. Genetic engineering of human pluripotent cells using TALE nucleases. Nat Biotechnol 2011, 29:731-734.
16. Miller J.C., Tan S., Qiao G., Barlow K.A., Wang J., Xia D.F., Meng X., Paschon D.E., Leung E., Hinkley S.J., et al. A TALE nuclease architecture for efficient genome editing. Nat Biotechnol 2011, 29:143-148.
17. Li Y., Moore R., Guinn M., Bleris L. Transcription activator-like effector hybrids for conditional control and rewiring of chromosomal transgene expression. Sci Rep 2012, 2:897.
18. Mali P., Yang L., Esvelt K.M., Aach J., Guell M., DiCarlo J.E., Norville J.E., Church G.M. RNA-guided human genome engineering via Cas9. Science 2013, 339:823-826.
19. Mali P., Aach J., Stranges P.B., Esvelt K.M., Moosburner M., Kosuri S., Yang L., Church G.M. CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat Biotechnol 2013.
20. Sorek R., Lawrence C.M., Wiedenheft B. CRISPR-mediated adaptive immune systems in bacteria and archaea. Annu Rev Biochem 2013, 82:237-266.
21. Gottesman S. The small RNA regulators of Escherichia coli: roles and mechanisms. Annu Rev Microbiol 2004, 58:303-328.
22. Boch J., Bonas U. Xanthomonas AvrBs3 family-type III effectors: discovery and function. Annu Rev Phytopathol 2010, 48:419-436.
23. Bogdanove A.J., Schornack S., Lahaye T. TAL effectors: finding plant genes for disease and defense. Curr Opin Plant Biol 2010, 13:394-401.
24. Mak A.N.-S., Bradley P., Bogdanove A.J., Stoddard B.L. TAL effectors: function, structure, engineering and applications. Curr Opin Struct Biol 2013, 23:93-99.
25. Boch J., Scholze H., Schornack S., Landgraf A., Hahn S., Kay S., Lahaye T., Nickstadt A., Bonas U. Breaking the code of DNA binding specificity of TAL-type III effectors. Science 2009, 326:1509-1512.
26. Moscou M.J., Bogdanove A.J. A simple cipher governs DNA recognition by TAL effectors. Science 2009, 326:1501.
27. Stella S., Molina R., Yefimenko I., Prieto J., Silva G., Bertonati C., Juillerat A., Duchateau P., Montoya G. Structure of the AvrBs3-DNA complex provides new insights into the initial thymine-recognition mechanism. Acta Crystallogr D Biol Crystallogr 2013, 69:1707-1716.
28. Deng D., Yan C., Pan X., Mahfouz M., Wang J., Zhu J.-K., Shi Y., Yan N. Structural basis for sequence-specific recognition of DNA by TAL effectors. Science 2012, 335:720-723.
29. Mak A.N., Bradley P., Cernadas R.A., Bogdanove A.J., Stoddard B.L. The crystal structure of TAL effector PthXo1 bound to its DNA target. Science 2012, 335:716-719.
30. Politz M.C., Copeland M.F., Pfleger B.F. Artificial repressors for controlling gene expression in bacteria. Chem Commun (Camb) 2013, 49:4325-4327.
31. Schlax P.J., Capp M.W., Record M.T. Inhibition of transcription initiation by lac repressor. J Mol Biol 1995, 245:331-350.
32. Browning D.F., Busby S.J.W. The regulation of bacterial transcription initiation. Nat Rev Microbiol 2004, 2:57-65.
33. Lamb B.M., Mercer A.C., Barbas C.F. Directed evolution of the TALE N-terminal domain for recognition of all 5' bases. Nucleic Acids Res 2013.
34. Meckler J.F., Bhakta M.S., Kim M.-S., Ovadia R., Habrian C.H., Zykovich A., Yu A., Lockwood S.H., Morbitzer R., Elsäesser J., et al. Quantitative analysis of TALE-DNA interactions suggests polarity effects. Nucleic Acids Res 2013, 41:4118-4128.
35. Christian M.L., Demorest Z.L., Starker C.G., Osborn M.J., Nyquist M.D., Zhang Y., Carlson D.F., Bradley P., Bogdanove A.J., Voytas D.F. Targeting G with TAL effectors: a comparison of activities of TALENs constructed with NN and NK repeat variable di-residues. PLoS ONE 2012, 7:e45383.
36. Cong L., Zhou R.H., Kuo Y.C., Cunniff M., Zhang F. Comprehensive interrogation of natural TALE DNA-binding modules and transcriptional repressor domains. Nat Commun 2012, 3.
37. Streubel J., Blücher C., Landgraf A., Boch J. TAL effector RVD specificities and efficiencies. Nat Biotechnol 2012, 30:593-595.
38. Zhang F., Cong L., Lodato S., Kosuri S., Church G.M., Arlotta P. Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription. Nat Biotechnol 2011, 29:149-153.
39. Liang J., Chao R., Abil Z., Bao Z., Zhao H. FairyTALE: a high-throughput TAL effector synthesis platform. ACS Synth Biol 2013.
40. Schmid-Burgk J.L., Schmidt T., Kaiser V., Höning K., Hornung V. A ligation-independent cloning technique for high-throughput assembly of transcription activator-like effector genes. Nat Biotechnol 2012.
41. Briggs A.W., Rios X., Chari R., Yang L., Zhang F., Mali P., Church G.M. Iterative capped assembly: rapid and scalable synthesis of repeat-module DNA such as TAL effectors from individual monomers. Nucleic Acids Res 2012.
42. Garg A., Lohmueller J.J., Silver P.A., Armel T.Z. Engineering synthetic TAL effectors with orthogonal target sites. Nucleic Acids Res 2012.
43. Horvath P., Barrangou R. CRISPR/Cas, the immune system of bacteria and Archaea. Science 2010, 327:167-170.
44. Wiedenheft B., Sternberg S.H., Doudna J.A. RNA-guided genetic silencing systems in bacteria and archaea. Nature 2012, 482:331-338.
45. Deltcheva E., Chylinski K., Sharma C.M., Gonzales K., Chao Y., Pirzada Z.A., Eckert M.R., Vogel J., Charpentier E. CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 2011, 471:602-607.
46. Perez-Pinera P., Kocak D.D., Vockley C.M., Adler A.F., Kabadi A.M., Polstein L.R., Thakore P.I., Glass K.A., Ousterout D.G., Leong K.W., et al. RNA-guided gene activation by CRISPR-Cas9-based transcription factors. Nat Methods 2013, 10:973-976.
47. Maeder M.L., Linder S.J., Cascio V.M., Fu Y., Ho Q.H., Joung J.K. CRISPR RNA-guided activation of endogenous human genes. Nat Methods 2013, 10:977-979.
48. Qi L.S., Larson M.H., Gilbert L.A., Doudna J.A., Weissman J.S., Arkin A.P., Lim W.A. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 2013, 152:1173-1183.
49. Bikard D., Jiang W., Samai P., Hochschild A., Zhang F., Marraffini L.A. Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system. Nucleic Acids Res 2013.
50. Jinek M., Chylinski K., Fonfara I., Hauer M., Doudna J.A., Charpentier E: A. DNA programmable dual-RNA-guided, endonuclease in adaptive bacterial immunity. Science 2012, 337:816-821.
51. Larson M.H., Gilbert L.A., Wang X., Lim W.A., Weissman J.S., Qi L.S. CRISPR interference (CRISPRi) for sequence-specific control of gene expression. Nat Protoc 2013, 8:2180-2196.
52. Mojica F.J., Diez-Villasenor C., Garcia-Martinez J., Almendros C. Short motif sequences determine the targets of the prokaryotic CRISPR defence system. Microbiology 2009, 155:733-740.
53. Semenova E., Jore M.M., Datsenko K.A., Semenova A., Westra E.R., Wanner B., van der Oost J., Brouns S.J., Severinov K. Interference by clustered regularly interspaced short palindromic repeat (CRISPR) RNA is governed by a seed sequence. Proc Natl Acad Sci U S A 2011, 108:10098-10103.
54. Carroll D. Staying on target with CRISPR-Cas. Nat Biotech 2013, 31:807-809.
55. Gottesman S. Micros for microbes: non-coding regulatory RNAs in bacteria. Trends Genet 2005, 21:399-404.
56. De Lay N., Schu D.J., Gottesman S. Bacterial small RNA-based negative regulation: Hfq and its accomplices. J Biol Chem 2013, 288:7996-8003.
57. Carpousis A.J. The RNA degradosome of Escherichia coli: an mRNA-degrading machine assembled on RNase E. Annu Rev Microbiol 2007, 61:71-87.
58. Ji Y., Woodnutt G., Rosenberg M., Burnham M.K.R. Identification of essential genes in Staphylococcus aureus using inducible antisense RNA. Methods Enzymol 2002, 358:123-128.
59. Sharma V., Sakai Y., Smythe K.A., Yokobayashi Y. Knockdown of recA gene expression by artificial small RNAs in Escherichia coli. Biochem Biophys Res Commun 2013, 430:256-259.
60. Kang Z., Wang X., Li Y., Wang Q., Qi Q. Small RNA RyhB as a potential tool used for metabolic engineering in Escherichia coli. Biotechnol Lett 2012, 34:527-531.
61. Tummala S.B., Welker N.E., Papoutsakis E.T. Design of antisense RNA constructs for downregulation of the acetone formation pathway of Clostridium acetobutylicum. J Bacteriol 2003, 185:1923-1934.
62. Na D., Yoo S.M., Chung H., Park H., Park J.H., Lee S.Y. Metabolic engineering of Escherichia coli using synthetic small regulatory RNAs. Nat Biotechnol 2013, 31:170-174.
63. Sharma V., Yamamura A., Yokobayashi Y. Engineering artificial small RNAs for conditional gene silencing in Escherichia coli. ACS Synth Biol 2012, 1:6-13.
64. Man S., Cheng R., Miao C., Gong Q., Gu Y., Lu X., Han F., Yu W. Artificial trans-encoded small non-coding RNAs specifically silence the selected gene expression in bacteria. Nucleic Acids Res 2011, 39:e50.
65. Yoo S.M., Na D., Lee S.Y. Design and use of synthetic regulatory small RNAs to control gene expression in Escherichia coli. UNKNOWN 2013, 8:1694-1707.
66. Updegrove T.B., Correia J.J., Chen Y., Terry C., Wartell R.M. The stoichiometry of the Escherichia coli Hfq protein bound to RNA. RNA 2011, 17:489-500.
67. Perez-Pinera P., Ousterout D.G., Brunger J.M., Farin A.M., Glass K.A., Guilak F., Crawford G.E., Hartemink A.J., Gersbach C.A. Synergistic and tunable human gene activation by combinations of synthetic transcription factors. Nat Methods 2013, 10:239-242.
68. Qi L., Haurwitz R.E., Shao W.J., Doudna J.A., Arkin A.P. RNA processing enables predictable programming of gene expression. Nat Biotechnol 2012, 30. 1002-+.
69. Esvelt K.M., Mali P., Braff J.L., Moosburner M., Yaung S.J., Church G.M. Orthogonal Cas9 proteins for RNA-guided gene regulation and editing. Nat Methods 2013, 10:1116-1121.
70. Levine E., Zhang Z., Kuhlman T., Hwa T. Quantitative characteristics of gene regulation by small RNA. PLoS Biol 2007, 5:1998-2010.
71. Mercer A.C., Gaj T., Sirk S.J., Lamb B.M., Barbas Iii C.F. Regulation of endogenous human gene expression by ligand-inducible TALE transcription factors. ACS Synth Biol 2013.